대한화학회지 (Journal of the Korean Chemical Society)

  • 제55권5호
  • /
  • Pages.787-793
  • /
  • 2011
  • /
  • 1017-2548(pISSN)
  • /
  • 2234-8530(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Zinc (II) [tetra(4-methylphenyl)] Porphyrin: a Novel and Reusable Catalyst for Efficient Synthesis of 2,4,5-trisubstituted Imidazoles Under Ultrasound Irradiation

  • Safari, Javad (Department of Organic Chemistry, College of Chemistry, University of Kashan) ;
  • Khalili, Shiva Dehghan (Department of Organic Chemistry, College of Chemistry, University of Kashan) ;
  • Banitaba, Sayed Hossein (Department of Organic Chemistry, College of Chemistry, University of Kashan) ;
  • Dehghani, Hossein (Department of Inorganic Chemistry, College of Chemistry, University of Kashan)
  • 투고 : 2011.05.29
  • 심사 : 2011.07.27
  • 발행 : 2011.10.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

An efficient three-component one-step synthesis of 2,4,5-trisubstituted imidazoles by condensation reaction of 1,2-diketones or ${\alpha}$-hydroxyketones with aromatic aldehydes and ammonium acetate using Zinc (II) [tetra (4-methylphenyl)] porphyrin as a novel and reusable catalyst under ultrasound irradiation at ambient temperature is described. In this method, ${\alpha}$-hydroxyketones as well as 1,2-diketones were converted to their corresponding 2,4,5-trisubstituted imidazoles in excellent yields.

키워드

INTRODUCTION

Multicomponent reactions (MCRs) have drawn great interest enjoying an outstanding status in modern organic synthesis and medicinal chemistry because they are onepot processes bringing together three or more components and show high atom economy and high selectivity.1-4 MCRs have great contribution in convergent synthesis of complex and important organic molecules from simple and readily available starting materials, and have emerged as powerful tools for drug discovery.5-7 Ultrasound has increasingly been used in organic synthesis. A large number of ultrasonic reactions can be carried out in higher yield, shorter reaction time or milder conditions.8-11 The phenomenon responsible for the beneficial effects of ultrasound on chemical reactions is cavitation. During the rarefaction cycle of the wave, the molecules of the liquid are separated, generating bubbles that subsequently collapse in the compression cycle.12 These rapid and violent implosions generate short-lived regions with temperatures of roughly 5000 ℃, pressures of about 1000 atm and heating and cooling rates above 10 billion ℃ per second.13 Such localized hot spots can be thought as microreactors in which the energy of sound is transformed into a useful chemical form.

The imidazole ring system is one of the most important substructures found in a large number of natural products and pharmacologically active compounds.14 Multisubstituted imidazoles have received much attention because of their wide range of pharmaceutical and biological properties such as antitumor,15 anti-inflammatory,16,17 antiallergic,18 analgesic19 and antibacterial effects.20 Various substituted imidazoles act as inhibitors of p38 MAP kinase21 and B-Raf kinase22 and glucagon receptors.23 Accordingly, a number of synthetic methods have been reported for the construction of this important structure. Generally 2,4,5-trisubstituted imidazoles are synthesized by three-component cyclocondensation of 1,2-diketone, α-hydroxyketone or α-ketomonoxime with an aldehyde and ammonium acetate. A variety of catalysts including protonic and Lewis acid catalysts have been introduced for synthesis of 2,4,5-trisubstituted imidazoles such as H2SO4,24 H3PO4,25 NiCl2·6H2O,26 Yb(OTf)3,27 InCl3·3H2O,28 I2,29 polymer-supported ZnCl2,30 oxalic acid,31 boric acid,32 p-toluenesulfonic acid,33 L-proline,34 L-proline triflate,35 Cu(NO3)2-zeolite,36 and ionic liquids.37-39 Despite their potential utility, most of these methods have a number of drawbacks including poor yields, high temperature, use of toxic catalyst, strongly acidic conditions and the requirement for harsh reaction conditions. Therefore, the development of facile and environmentally benign method for the synthesis of biologically active 2,4,5-trisubstituted imidazoles is the necessary part of organic synthesis. Electron-deficient metalloporphyrins have been used as mild and non-toxic Lewis acid catalysts.40-44 In continuation of our interest on the synthesis of 2,4,5-trisubstituted imidazoles,45,46 we decided to explore ability of metalloporphyrins in the synthesis of 2,4,5-trisubstituted imidazoles for the first time. Therefore, Zinc (II) [tetra (4-methylphenyl)] porphyrin was used as a mild Lewis acid catalyst for the three-component one-step synthesis of 2,4,5-trisubstituted imidazoles by condensation reaction of 1,2-diketones or α-hydroxyketones with aromatic aldehydes and ammonium acetate under ultrasound irradiation at ambient temperature (Scheme 1).

Scheme 1.One-pot synthesis of 2,4,5-trisubstituted imidazoles catalyzed by [ZnT(4-CH3)PP] under ultrasound irradiation at ambient temperature.

 

EXPERIMENTAL

Chemical reagents in high purity were purchased from the Merck Chemical Company. All materials were of commercial reagent grade. Zinc (II) [tetra (4-methylphenyl)] porphyrin was prepared and metallated according to the literature.47,48 Melting points were determined in open capillaries using an Electrothermal Mk3 apparatus and are uncorrected. FT-IR spectra were obtained with potassium bromide pellets in the range 400-4000 cm-1 with a Perkin-Elmer 550 spectrometer. 1H NMR and 13C NMR spectra were recorded with a Bruker DRX-400 spectrometer at 400 and 100 MHz respectively. NMR spectra were obtained in DMSO-d6 solutions and are reported as parts per million (ppm) downfield from tetramethylsilane as internal standard. The abbreviations used are: singlet (s), doublet (d), triplet (t) and multiplet (m). Elemental analysis (C, H, N) was performed with a Carlo Erba Model EA 1108 analyzer or a Perkin-Elmer 240c analyzer, and results agreed favorably with calculated values. The UV-vis measurements were obtained with a GBC cintra 6 UV-vis spectrophotometer. Ultrasonication was performed in a EUROSONIC® 4D ultrasound cleaner with a frequency of 50 kHz and an output power of 350 W. The reaction ask was located in the maximum energy area in the cleaner, where the surface of reactants (reaction vessel) is slightly lower than the level of the water and the temperature of the water bath was controlled at 25 ℃.

General procedure for the synthesis of 2,4,5-trisubstituted imidazoles catalyzed by [ZnT(4-CH3)PP] under ultrasound irradiation

A mixture of benzoin or benzil derivatives (1 mmol), aldehyde (1 mmol), ammonium acetate (0.31 g, 4 mmol) and [ZnT(4-CH3)PP] (3 μmol %) in 10 ml ethanol was taken in a 50 ml conical flask and the reaction mixture was irradiated in the water bath of the ultrasonic cleaner at 25 ℃ for a period as indicated in Table 2 and Table 3. The progress of reaction was followed by TLC. After completion of reaction, the solvent was evaporated, then the solid residue was purified by column chromatography (eluent petroleum ether: ethyl acetate=9:2) on silica gel to give analytically pure products in good to excellent yield and were fully characterized by spectroscopic methods such as IR, 1H NMR, 13C NMR and element analyses (C, H, N) and have been identified by the comparison of the reported spectral data. The spectral data for new compounds are presented below.

Spectroscopic data for new 2,4,5-trisubstituted imidazoles

3-[4,5-bis(4-methoxyphenyl)-1H-imidazol-2-yl]phenol (5n). Cream solid. IR (KBr) (υmax/cm-1): 3415 (N-H), 3338 (O-H), 1613 (C=C), 1500 (C=N), 1247 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.42 (s, 1H, NH), 9.52 (s, 1H, OH), 7.38-7.49 (m, 6H, Ar-H), 7.23 (t, 1H, J=8.0 Hz, Ar-H), 7.00 (d, 2H, J=8.4 Hz, Ar-H), 6.86 (d, 2H, J=8.4 Hz, Ar-H), 6.74 (dd, 1H, J=8.0, 2.8 Hz, Ar-H), 3.78 (s, 3H, OMe), 3.73 (s, 3H, OMe) ppm; 13C NMR (100 MHz, DMSO-d6): δC 159.2, 158.4, 158.0, 145.4, 136.7, 132.2, 130.2, 130.1, 128.6, 128.4, 127.5, 124.0, 116.4, 115.6, 114.5, 114.1, 112.5, 55.6, 55.5 ppm; Anal. Calcd. for C23H20N2O3: C, 74.18; H, 5.41; N, 7.52 %. Found: C, 74.16; H, 5.39; N, 7.49%.

2-(3-nitrophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole (5o). Yellow solid. IR (KBr) (υmax/cm-1): 3428 (NH), 1615 (C=C), 1523 (C=N), 1460 (N=O), 1348 (N-O), 1249 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.92 (s, 1H, NH), 8.92 (s, 1H, Ar-H), 8.50 (d, 1H, J=8.2 Hz, Ar-H), 8.20 (d, 1H, J=8.2 Hz, Ar-H), 7.75 (t, 1H, J=8.2 Hz, Ar-H), 7.47 (d, 2H, J=8.4 Hz, Ar-H), 7.43 (d, 2H, J=8.4 Hz, Ar-H), 7.00 (d, 2H, J=8.4 Hz, Ar-H), 6.90 (d, 2H, J=8.4 Hz, Ar-H), 3.80 (s, 3H, OMe), 3.75 (s, 3H, OMe) ppm; 13C NMR (100 MHz, DMSO-d6): δC 159.4, 158.6, 148.8, 143.1, 137.5, 132.5, 131.4, 130.8, 130.2, 128.8, 128.7, 127.9, 123.5, 122.7, 119.7, 114.6, 114.1, 55.7, 55.5 ppm; Anal. Calcd. for C23H19N3O4: C, 68.82; H, 4.77; N, 10.47%. Found: C, 68.79; H, 4.75; N, 10.44%.

2-(3-methoxyphenyl)-4,5-bis(4-methoxyphenyl)-1Himidazole (5p). White solid. IR (KBr) (υmax/cm-1): 3430 (N-H), 1608 (C=C), 1519 (C=N), 1246 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.50 (s, 1H, NH), 7.64 (d, 1H, J=8.0 Hz, Ar-H), 7.62 (s, 1H, Ar-H), 7.36-7.46 (m, 5H, Ar-H), 7.00 (d, 2H, J=8.4 Hz, Ar-H), 6.91 (dd, 1H, J=8.4, 2.2 Hz, Ar-H), 6.87 (d, 2H, J=8.4 Hz, Ar-H), 3.82 (s, 3H, OMe), 3.79 (s, 3H, OMe), 3.74 (s, 3H, OMe) ppm; 13C NMR (100 MHz, DMSO-d6): δC 160.0, 158.9, 158.2, 145.1, 136.2, 132.3, 130.2, 130.2, 128.6, 128.2, 127.2, 124.1, 117.0, 115.5, 114.4, 114.3, 110.5, 55.6, 55.5, 55.5 ppm; Anal. Calcd. for C24H22N2O3: C, 74.59; H, 5.74; N, 7.25%. Found: C, 74.58; H, 5.75; N, 7.24%.

5-[4,5-bis(4-methoxyphenyl)-1H-imidazol-2-yl]-2-methoxyphenol (5q). Ash-gray solid. IR (KBr) (υmax/cm-1): 3424 (N-H), 3320 (O-H), 1615 (C=C), 1504 (C=N), 1249 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.26 (s, 1H, NH), 9.11 (s, 1H, OH), 7.52 (s, 1H, Ar-H), 7.37-7.46 (m, 6H, Ar-H), 6.98 (d, 2H, J= 8.4 Hz, Ar-H), 6.86 (d, 2H, J= 8.4 Hz, Ar-H), 3.80 (s, 3H, OMe), 3.78 (s, 3H, OMe), 3.73 (s, 3H, OMe) ppm; 13C NMR (100 MHz, DMSO-d6): δC 159.1, 158.7, 148.4, 146.9, 145.6, 129.8, 129.2, 128.4, 126.3, 126.0, 123.5, 124.1, 116.8, 114.3, 114.0, 113.2, 112.5, 56.1, 55.5, 55.1 ppm; Anal. Calcd. for C24H22N2O4: C, 71.63; H, 5.51; N, 6.96%. Found: C, 71.61; H, 5.49; N, 6.95%.

2-(3,5-dimethoxyphenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole (5r). White solid. IR (KBr) (υmax/cm-1): 3420 (N-H), 1604 (C=C), 1519 (C=N), 1248 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.50 (s, 1H, NH), 7.45 (d, 2H, J=7.6 Hz, Ar-H), 7.40 (d, 2H, J=8.0 Hz, Ar-H), 7.26 (s, 2H, Ar-H), 7.0 (d, 2H, J=8.0 Hz, Ar-H), 6.87 (d, 2H, J=8.0 Hz, Ar-H), 6.48 (s, 1H, Ar-H), 3.80 (s, 3H, OMe), 3.79 (s, 3H, OMe), 3.73 (s, 6H, OMe), ppm; 13C NMR (100 MHz, DMSO-d6): δC 161.2, 158.9, 158.1, 145.1, 137.0, 134.3, 132.8, 130.1, 128.8, 128.6, 124.0, 114.3, 114.1, 103.4, 100.8, 55.8, 55.5 ppm; Anal. Calcd. for C25H24N2O4: C, 72.10; H, 5.81; N, 6.73%. Found: C, 72.09; H, 5.79; N, 6.72%.

2-(4-methoxyphenyl)-4,5-bis(4-fluorophenyl)-1H-imidazole (5s). White solid. IR (KBr) (υmax/cm-1): 3427 (NH), 1613 (C=C), 1504 (C=N), 1248 (C-O); 1H NMR (400 MHz, DMSO-d6): δH 12.53 (s, 1H, NH), 8.0 (d, 2H, J=8.4 Hz, Ar-H), 7.48-7.53 (m, 4H, Ar-H), 7.28 (t, 2H, J=8.8 Hz, Ar-H), 7.14 (t, 2H, J=8.8 Hz, Ar-H), 7.03 (d, 2H, J=8.4 Hz, Ar-H), 3.80 (s, 3H, OMe) ppm; 13C NMR (100 MHz, DMSO-d6): δC 163.0 (C-F, d, J=243.0 Hz), 160.6 (C-F, d, J=241.0 Hz), 159.0, 146.2, 146.2, 133.5 (d, J=10.0 Hz), 130.2 (d, J=9.0 Hz), 129.5, 129.3, 127.5, 123.5, 117.2 (d, J=22.0 Hz), 115.8 (d, J=21.0 Hz), 114.5, 112.3, 55.6 ppm; Anal. Calcd. for C22H16F2N2O: C, 72.92; H, 4.45; N, 7.73%. Found: C, 72.89; H, 4.43; N, 7.71%.

3-[4,5-bis(4-fluorophenyl)-1H-imidazol-2-yl]phenol (5t). Golden crystalline solid. IR (KBr) (υmax/cm-1): 3437 (N-H), 3300 (O-H), 1605 (C=C), 1517 (C=N); 1H NMR (400 MHz, DMSO-d6): δH 12.62 (s, 1H, NH), 9.54 (s, 1H, OH), 7.45-7.58 (m, 6H, Ar-H), 7.30 (t, 2H, J=7.6 Hz, Ar-H), 7.24 (d, 1H, J=8.0 Hz, Ar-H), 7.15 (t, 2H, J=8.3 Hz, Ar-H), 6.78 (d, 1H, J=8.0 Hz, Ar-H) ppm; 13C NMR (100 MHz, DMSO-d6): δC 162.2 (C-F, d, J=243.0 Hz), 161.6 (C-F, d, J=243.0 Hz), 160.1, 145.9, 136.7, 132.0, 131.9, 131.1 (d, J=7.0 Hz), 130.3, 129.4 (d, J=7.0 Hz), 127.8, 127.6, 118.1, 116.1 (d, J=21.0 Hz), 115.6 (d, J=22.0 Hz), 114.7, 110.7 ppm; Anal. Calcd. for C21H14F2N2O: C, 72.41; H, 4.05; N, 8.04%. Found: C, 72.38; H, 4.04; N, 8.02%.

 

RESULTS AND DISCUSSION

To achieve suitable conditions for the synthesis of 2,4,5-trisubstituted imidazoles, various reaction conditions have been investigated in the reaction of 4-methoxybenzaldehyde 3b, benzil 1a, and ammonium acetate as a model reaction. We examined the effect of different solvents such as water, EtOH, THF, DMF, CH3CN, and CHCl3 on a model reaction under ultrasound irradiation at 25 ℃ (Table 1, entry 1-6). The reaction using EtOH as solvent gave the best result and 5b was obtained in 80% yield within 70 min (Table 1, entry 2). To demonstrate the effect of ultrasound, the synthesis of 5b as a model was investigated under high speed stirring conditions. The reaction failed to give low yield under high speed stirring conditions (Table 1, entry 7). It was apparent that the ultrasound irradiation accelerates this transformation under ambient conditions. To delineate the role of catalyst, the reaction was investigated with and without catalyst. As shown, in the absence of catalyst the yield of the product was found to be low (Table 1, entry 8). On the other hand, ultrasound irradiation and the catalyst have a great influence on the model reaction. As indicated (Table 1, entry 12) the best result have been obtained with amount of 3 μmol% [ZnT(4-CH3)PP] in EtOH under ultrasound irradiation at ambient temperature and the yield of reaction with increasing the amount of [ZnT(4-CH3)PP] is not increased (Table 1, entry 13).

Table 1.aBenzil (1 mmol), 4-methoxybenzaldehyde (1 mmol), NH4OAc (4 mmol), bIsolated yield based on aldehyde.

Table 2.aBenzil (1 mmol), Aldehyde (1 mmol), NH4OAc (4 mmol), [ZnT(4-CH3)PP] (3 μmol %), bIsolated yield based on aldehyde.

In order to evaluate the generality of the process, several diversified examples illustrating the present method for the synthesis of 2,4,5-trisubstituted imidazoles 5a-t were studied. The reaction of benzil with various aromatic aldehydes bearing electron-withdrawing groups or electronreleasing groups and ammonium acetate was carried out in the presence of [ZnT(4-CH3)PP] as catalyst under ultrasound irradiation at ambient temperature (Table 2). As shown the process tolerates both electron withdrawing and electron donating substituents on the aldehydes. The aryl group substituted with different positions of the aromatic ring has not shown much effect on the formation of the final product. We also concentrated our study on different benzils (4,4'-difluorobenzil, 4,4'-dimethoxybenzil) (Table 2). The results illustrate the high ability of this method for the synthesis of 2,4,5-triarylimidazoles with different groups.

The reusability of the [ZnT(4-CH3)PP] catalyst was studied using multiple synthesis of 2,4,5-trisubstituted imidazoles. The results showed that after reusing the catalyst for several times, no change was observed in its catalytic activity. The nature of the recovered catalyst was monitored by its UV-Vis spectrum Fig. 1, in which no change was observed in its spectrum and since the catalyst retained its activity in the condensation reaction.

Fig. 1.UV-Vis spectrum of [ZnT(4-CH3)PP]: before reaction (solid line) and after reaction (dashed line).

Table 3.aBenzoin (1 mmol), Aldehyde (1 mmol), NH4OAc (4 mmol), [ZnT(4-CH3)PP] (3 μmol %), b Isolated yield based on aldehyde.

Scheme 2.Plausible mechanism.

We have not established an exact mechanism for the formation of 2,4,5-trisubstituted imidazoles, however, a reasonable possibility is shown in Scheme 2. A plausible mechanism for these reactions is that aldehyde and 1,2-diketone are first activated by [ZnT(4-CH3)PP] to afford A and B respectively. Then, imine intermediate (A), condenses further with the carbonyl carbon of 1,2 diketone imine (B) and formation of carbocation (C) followed by attack imine nitrogen to positive center and dehydration to afford the iso-imidazole (E), which rearranges via [1,5] sigmatropic shift to the required imidazole (Scheme 2).

The high catalytic activity of [ZnT(4-CH3)PP] catalyst in the synthesis of trisubstituted imidazoles by condensation reaction of benzil derivatives, aromatic aldehyde and ammonium acetate under ultrasound irradiation, prompted us to explore its catalytic activity in the condensation of benzoin or p-anisoin, aldehyde and ammonium acetate. The synthesis of different trisubstituted imidazoles with benzoin derivatives was carried out under the same reaction conditions which applied for benzil derivatives and the corresponding trisubstituted imidazoles were obtained in high yields (Table 3).

 

CONCLUSION

In summary an efficient and convenient procedure for the three-component one-step synthesis of 2,4,5-trisubstituted imidazoles has been developed by condensation reaction of 1,2-diketones or α-hydroxyketones, aromatic aldehydes, and ammonium acetate using [ZnT(4-CH3)PP] as a novel and reusable catalyst under ultrasound irradiation at ambient temperature. Benzoin as well as benzil efficiently converted to their corresponding 2,4,5-trisubstituted imidazoles. The approach has several advantages, for example high yields, easy work up, reusability of catalyst, and applicability for both 1,2-diketones and α-hydroxyketones.

참고문헌

  1. Ugi, I. Pure Appl. Chem. 2001, 73, 187. https://doi.org/10.1351/pac200173010187
  2. Domling, A. Chem. Rev. 2006, 106, 17. https://doi.org/10.1021/cr0505728
  3. D'Souza, D. M.; Mueller, T. J. Chem. Soc. Rev. 2007, 36, 1098.
  4. Cariou, C. C. A.; Clarkson, G. J.; Shipman M. J. Org. Chem. 2008, 73, 9762. https://doi.org/10.1021/jo801664g
  5. Hulme, C.; Gore, V. Curr. Med. Chem. 2003, 10, 51. https://doi.org/10.2174/0929867033368600
  6. Tempest, P. A. Curr. Opin. Drug Discov. Dev. 2005, 8, 776.
  7. Kalinski, C.; Lemoine, H.; Schmidt, J.; Burdack, C.; Kolb, J.; Umkehrer, M.; Ross, G. Synlett 2008, 4007.
  8. Mason, T. J.; Peters, D. Practical sonochemistry, 2nd ed.; EllisHorwood: London, 2002.
  9. Luche, J. L. Synthetic organic sonochemistry; Plenum Press: New York, 1998.
  10. Zang, H.; Zhang, Y.; Zang, Y.; Cheng, B. W. Ultrason. Sonochem. 2010, 17, 495. https://doi.org/10.1016/j.ultsonch.2009.11.003
  11. Li, J. T.; Yin, Y.; Sun, M. X. Ultrason. Sonochem. 2010, 17, 363. https://doi.org/10.1016/j.ultsonch.2009.09.007
  12. Mason, T. J.; Lorimer, J. P. Applied sonochemistry: the uses of power ultrasound in chemistry and processing; Wiley-VCH GmbH and Co. KGaA: Weinheim, 2002.
  13. Pizzuti, L.; Martins, P. L. C.; Ribeiro, B. A.; Quina, F. H.; Pinto, E.; Flores, A. F. C.; Venzke, D.; Pereira, C. M. P. Ultrason. Sonochem. 2010, 17, 34. https://doi.org/10.1016/j.ultsonch.2009.06.013
  14. Wolkenberg, S. E.; Wisnoski, D. D.; Leister, W. H.; Wang, Y.; Zhao, Z.; Lindsley, C. W. Org. Lett. 2004, 6, 1453. https://doi.org/10.1021/ol049682b
  15. Wang, L.; Woods, K. W.; Li, Q.; Barr, K. J.; McCroskey, R. W.; Hannick, S. M.; Gherke, L.; Credo, R. B.; Hui, Y. H.; Marsh, K.; Warner, R.; Lee, J. Y.; Zielinsky-Mozng, N.; Frost, D.; Rosenberg, S. H.; Sham, H. L. J. Med. Chem. 2002, 45, 1697. https://doi.org/10.1021/jm010523x
  16. Lombardino, J. G.; Wiseman, E. H. J. Med. Chem. 1974, 17, 1182. https://doi.org/10.1021/jm00257a011
  17. Lombardino, J. G. US Patent 1973, 3772441.
  18. Black, J. W.; Durant, G. J.; Emmett, J. C.; Ganellin, C. R. Nature 1974, 24, 865.
  19. Ucucu, U.; Karaburun, N. G.; Iskdag, I. Il Farmaco 2001, 56, 285. https://doi.org/10.1016/S0014-827X(01)01076-X
  20. Khan, M. S.; Siddiqui, S. A.; Siddiqui, M. S. R.; Goswami, U.; Srinivasan, K. V.; Khan, M. I. Chem. Biol. Drug. Des. 2008, 72, 197. https://doi.org/10.1111/j.1747-0285.2008.00691.x
  21. Lee, J. C.; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Keys, J.R.; Vatter, S.W.L.; Strickler, J.E.; McLaughlin, M. M.; Siemens, I. R.; Fisher, S. M.; Livi, G. P.; White, J. R.; Adams, J. L.; Young, P. R. Nature 1994, 372, 739. https://doi.org/10.1038/372739a0
  22. Takle, A. K.; Brown, M. J. B.; Davies, S.; Dean, D. K.; Francis, G.; Gaiba, A.; Hird, A. W.; King, F. D.; Lovell, P. J.; Naylor, A.; Reith, A. D.; Steadman, J. G.; Wilson, D. M. Bioorg. Med. Chem. Lett. 2006, 16, 378. https://doi.org/10.1016/j.bmcl.2005.09.072
  23. Chang, L. L.; Sidler, K. L.; Cascieri, M. A.; Laszlo, S. D.; Koch, G.; Li, B.; MacCoss, M.; Mantlo, N.; O'Keefe, S.; Pang, M.; Rolando, A.; Hagmann, W. K. Bioorg. Med. Chem. Lett. 2001, 11, 2549. https://doi.org/10.1016/S0960-894X(01)00498-X
  24. Weinmann, H.; Harre, M.; Koeing, K.; Merten, E.; Tilestam, U. Tetrahedron Lett. 2002, 43, 593. https://doi.org/10.1016/S0040-4039(01)02226-2
  25. Liu, J.; Chen, J.; Zhao, J.; Zhao, Y.; Li, L.; Zhang, H. Synthesis 2003, 2661.
  26. Heravi, M. M.; Bakhtiari, K.; Oskooie, H. A.; Taheri, S. J. Mol. Catal. A: Chem. 2007, 263, 279. https://doi.org/10.1016/j.molcata.2006.08.070
  27. Wang, L.; Wang, Y.; Tian, H.; Yao, Y.; Shao, J.; Liu, B. J. Fluorine Chem. 2006, 127, 1570. https://doi.org/10.1016/j.jfluchem.2006.08.005
  28. Sharma, S. D.; Hazarika, P.; Konwar, D. Tetrahedron Lett. 2008, 49, 2216. https://doi.org/10.1016/j.tetlet.2008.02.053
  29. Kidwai, M.; Mothsra, P.; Bansal, V.; Somvanshi, R. K.; Ethayathulla, A. S.; Dey, S.; Singh, T. P. J. Mol. Catal. A: Chem. 2007, 265, 177. https://doi.org/10.1016/j.molcata.2006.10.009
  30. Wang, L.; Cai, C. Monatsh. Chem. 2009, 140, 541. https://doi.org/10.1007/s00706-008-0086-2
  31. Kokare, N. D.; Sangshetti, J. N.; Shinde, D. B. Synthesis 2007, 2829.
  32. Shelke, K. F.; Sapkal, S. B.; Sonar, S. S.; Madje, B. R.; Shingate, B. B.; Shingare, M. S. Bull. Korean Chem. Soc. 2009, 30, 1057. https://doi.org/10.5012/bkcs.2009.30.5.1057
  33. Khodaei, M. M.; Bahrami, K.; Kavianinia, I. J. Chin. Chem. Soc. 2007, 54, 829.
  34. Samai, S.; Nandi, G. C.; Singh, P.; Singh, M. S. Tetrahedron 2009, 65, 10155. https://doi.org/10.1016/j.tet.2009.10.019
  35. Li, J.; Lin, S.; Dai, J.; Su, W. J. Chem. Res. 2010, 4, 196.
  36. Sivakumara, K.; Kathirvela, A.; Lalitha, A. Tetrahedron Lett. 2010, 51, 3018. https://doi.org/10.1016/j.tetlet.2010.04.013
  37. Chary, M. V.; Keerthysri, N. C.; Vupallapati, S.; Lingaiah, N.; Kantevari, S. Catal. Commun. 2008, 9, 2013. https://doi.org/10.1016/j.catcom.2008.03.037
  38. Zang, H.; Sua, Q.; Moa, Y.; Cheng, B.; Juna, S. Ultrason. Sonochem. 2010, 17, 749. https://doi.org/10.1016/j.ultsonch.2010.01.015
  39. Heravi, M. M.; Zakeri, M.; Karimi, N.; Saeedi, M.; Oskooie, H. A.; Tavakoli-Hosieni, N. Synth. Commun. 2010, 40, 1998. https://doi.org/10.1080/00397910903219377
  40. Tangestaninejad, S.; Mirkhani, V. Synth. Commun. 1999, 29, 2079. https://doi.org/10.1080/00397919908086200
  41. Takanami, T.; Hayashi, M.; Suda, K. Tetrahedron Lett. 2005, 46, 2893. https://doi.org/10.1016/j.tetlet.2005.02.136
  42. Suda, K.; Kikkawa, T.; Nakajima, S.; Takanami, T. J. Am. Chem. Soc. 2004, 126, 9554. https://doi.org/10.1021/ja047104k
  43. Moghadam, M.; Tangestaninejad, S.; Mirkhani, V.; Mohammadpoor-Baltork, I.; Gharaati, S. Polyhedron 2010, 29, 212. https://doi.org/10.1016/j.poly.2009.07.008
  44. Moghadam, M.; Tangestaninejad, S.; Mirkhani, V.; Mohammadpoor-Baltork, I.; Gharaati, S. Inorg. Chim. Acta 2010, 363, 1523. https://doi.org/10.1016/j.ica.2010.01.017
  45. Safari, J.; Dehghan Khalili, S.; Banitaba, S. H. J. Chem. Sci. 2010, 122, 437. https://doi.org/10.1007/s12039-010-0051-6
  46. Safari, J.; Dehghan Khalili, S.; Rezaei, M.; Banitaba, S. H.; Meshkani, F. Monatsh. Chem. 2010, 141, 1339. https://doi.org/10.1007/s00706-010-0397-y
  47. Adler, A. D.; Longo, F. R.; Finarelli, J. D.; Goldmacher, J.; Assour, J.; Korsakoff, L. J. Org. Chem. 1967, 32, 476.
  48. Adler, A. D.; Long, F. R.; Kampas, F.; Kim, J. J. Inorg. Nucl. Chem. 1970, 32, 2443. https://doi.org/10.1016/0022-1902(70)80535-8

피인용 문헌

  1. Catalytic activity of Cu nanoparticles supported on Fe3O4–polyethylene glycol nanocomposites for the synthesis of substituted imidazoles vol.38, pp.9, 2014, https://doi.org/10.1039/C4NJ00645C
  2. Synthesis of Novel Organosiliconsulfur-Containing Tetrasubstituted Imidazoles Sonocatalyzed by LaxSr1−xFeyCo1−yO3Nanoperovskites vol.45, pp.10, 2015, https://doi.org/10.1080/00397911.2015.1009552
  3. A Fast, Highly Efficient and Green Protocol for One-Pot Synthesis of 2,4,5-Trisubstituted Imidazoles Catalyzed by [TBA]2[W6O19] as a Reusable Heterogeneous Catalyst vol.34, pp.5, 2013, https://doi.org/10.5012/bkcs.2013.34.5.1508
  4. Sulphamic acid-functionalized magnetic Fe3O4 nanoparticles as recyclable catalyst for synthesis of imidazoles under microwave irradiation vol.125, pp.4, 2013, https://doi.org/10.1007/s12039-013-0462-2
  5. A highly efficient magnetic solid acid catalyst for synthesis of 2,4,5-trisubstituted imidazoles under ultrasound irradiation vol.20, pp.2, 2013, https://doi.org/10.1016/j.ultsonch.2012.10.004
  6. Synthesis of Novel Organosilicon Compounds Possessing Fully Substituted Imidazole Nucleus Sonocatalyzed by Fe-Cu/ZSM-5 Bimetallic Oxides vol.45, pp.3, 2015, https://doi.org/10.1080/00397911.2014.962056
  7. Nano Copper Ferrite Catalyzed Sonochemical, One-Pot Three and Four Component Synthesis of Poly Substituted Imidazoles vol.05, pp.01, 2016, https://doi.org/10.4236/mrc.2016.51004
  8. An efficient green MCR protocol for the synthesis of 2,4,5-trisubstituted imidazoles by Selectfluor™ under ultrasound irradiation vol.17, pp.2, 2014, https://doi.org/10.1016/j.crci.2012.12.007
  9. Synthesis of organosilyl compounds-containing 1,2,4,5-tetraaryl imidazoles sonocatalyzed by M/SAPO-34 (M = Fe, Co, Mn, and Cu) nanostructures vol.18, pp.8, 2015, https://doi.org/10.1016/j.crci.2015.04.008
  10. -EG-Cu(II)): A highly efficient magnetically separable heterogeneous nanocatalyst for one-pot synthesis of highly substituted imidazoles vol.32, pp.2, 2017, https://doi.org/10.1002/aoc.4095
  11. Molecular Modeling Studies of Halogenated Imidazoles against 14α- Demethylase from Candida Albicans for Treating Fungal Infections vol.20, pp.2, 2011, https://doi.org/10.2174/1871526519666181130101054